Cyp2d6-guided Dosing

CYP2D6-Guided Dosing is a personalized dosing strategy that uses genetic and enzymatic activity data of the CYP2D6 enzyme to tailor drug regimens according to an individual’s metabolic phenotype, thereby optimizing therapeutic efficacy and minimizing adverse effects.

87

Publications

5K

Citations

658

Authors

271

Institutions

Publications per year

2017–2026

23

Publications

87

1–5 of 87

Authors

658

  1. TC
    Todd C. Skaar

    Indiana University – Purdue University Indianapolis, United States

    6 publications · 1.1K citations

    6

    h-index

  2. AG
    Andrea Gaedigk

    Children's Mercy Hospital, United States

    5 publications · 1.6K citations

    5

    h-index

  3. HG
    Henk‐Jan Guchelaar

    Leiden University Medical Center, Netherlands

    5 publications · 278 citations

    5

    h-index

  4. RH
    Ron H. N. van Schaik

    Erasmus MC, Netherlands

    5 publications · 190 citations

    5

    h-index

  5. VO
    Vincent O. Dezentjé

    Leiden University Medical Center, Netherlands

    4 publications · 211 citations

    4

    h-index

1–5 of 658

Venues

  1. Breast Cancer Research and Treatment

    11 publications · 505 citations

    11

    h-index

  2. European Journal of Clinical Pharmacology

    10 publications · 379 citations

    10

    h-index

  3. Journal of Clinical Oncology

    4 publications · 355 citations

    4

    h-index

  4. Clinical Pharmacology & Therapeutics

    CPT · 4 publications · 1.6K citations

    4

    h-index

  5. Clinical Drug Investigation

    3 publications · 90 citations

    3

    h-index

1–5